Tapewire

Nasdaq · USD

TMCI

TREACE MEDICAL CONCEPTS, INC.

Export transactions ↓
Tapewire entity
5943
SEC CIK
0001630627
Parsed reports
290

Last 12 months

Inside the activity.

14 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202660
Jun 202650
Jul 202600
Aug 202630
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 19, 2022 Filed Jul 20, 2022 19:18 UTC SaleCommon Stock 20,239 $16.11 $326,092.79
Disclosure

SEC source: 0001567619-22-014272 · doc1.xml · nonDerivative · entry 3

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,236,441

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.62 to $16.54 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 18, 2022 Filed Jul 20, 2022 19:18 UTC SaleCommon Stock 983 $16.46 $16,177.03
Disclosure

SEC source: 0001567619-22-014272 · doc1.xml · nonDerivative · entry 2

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,256,680

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.39 to $16.51 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 18, 2022 Filed Jul 20, 2022 19:18 UTC SaleCommon Stock 12,978 $16.06 $208,400.72
Disclosure

SEC source: 0001567619-22-014272 · doc1.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,257,663

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.38 to $16.37 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2022 Filed Jul 15, 2022 18:07 UTC SaleCommon Stock 8,456 $16.18 $136,829.07
Disclosure

SEC source: 0001567619-22-014078 · doc1.xml · nonDerivative · entry 3

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,270,641

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.67 to $16.47 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 14, 2022 Filed Jul 15, 2022 18:07 UTC SaleCommon Stock 2,800 $16.03 $44,893.24
Disclosure

SEC source: 0001567619-22-014078 · doc1.xml · nonDerivative · entry 2

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,279,097

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.60 to $16.25 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 13, 2022 Filed Jul 15, 2022 18:07 UTC SaleCommon Stock 4,544 $16.13 $73,283.36
Disclosure

SEC source: 0001567619-22-014078 · doc1.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,281,897

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.82 to $16.3475 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 17:54 UTC
Owens Daniel E.Chief HR Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $7.03 $0.00
Disclosure

SEC source: 0001567619-22-013730 · doc1.xml · derivative · entry 3

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,625

Underlying: Common Stock · 1,000 shares

Expires 2031-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 17:54 UTC
Owens Daniel E.Chief HR Officer
SaleCommon Stock 1,000 $15.00 $15,000.00
Disclosure

SEC source: 0001567619-22-013730 · doc1.xml · nonDerivative · entry 2

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,700

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: Includes 6,700 RSUs.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 17:54 UTC
Owens Daniel E.Chief HR Officer
Exercise / conversionCommon Stock 1,000 $7.03 $7,028.00
Disclosure

SEC source: 0001567619-22-013730 · doc1.xml · nonDerivative · entry 1

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Includes 6,700 RSUs.

Read SEC document
June 17, 2022 Filed Jun 21, 2022 18:27 UTC SaleCommon Stock 29,191 $13.73 $400,909.19
Disclosure

SEC source: 0001567619-22-013208 · doc1.xml · nonDerivative · entry 2

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,286,441

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.52 to $14.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 18:27 UTC SaleCommon Stock 20,809 $13.58 $282,573.73
Disclosure

SEC source: 0001567619-22-013208 · doc1.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,315,632

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.33 to $14.04 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 17:12 UTC
Owens Daniel E.Chief HR Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $7.03 $0.00
Disclosure

SEC source: 0001567619-22-012339 · doc1.xml · derivative · entry 3

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,625

Underlying: Common Stock · 1,000 shares

Expires 2031-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 17:12 UTC
Owens Daniel E.Chief HR Officer
SaleCommon Stock 1,000 $16.67 $16,670.00
Disclosure

SEC source: 0001567619-22-012339 · doc1.xml · nonDerivative · entry 2

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,700

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: Includes 6,700 RSUs.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 17:12 UTC
Owens Daniel E.Chief HR Officer
Exercise / conversionCommon Stock 1,000 $7.03 $7,028.00
Disclosure

SEC source: 0001567619-22-012339 · doc1.xml · nonDerivative · entry 1

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Includes 6,700 RSUs.

Read SEC document
May 26, 2022 Filed May 27, 2022 18:39 UTC SaleCommon Stock 19,687 $15.77 $310,534.86
Disclosure

SEC source: 0001567619-22-011883 · doc1.xml · nonDerivative · entry 2

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,336,441

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.33 to $16.015 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 25, 2022 Filed May 27, 2022 18:39 UTC SaleCommon Stock 30,313 $15.35 $465,322.74
Disclosure

SEC source: 0001567619-22-011883 · doc1.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,356,128

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.06 to $15.71 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 18, 2022 Filed May 20, 2022 23:41 UTC
Hair MarkChief Financial Officer
PurchaseCommon Stock 6,200 $15.80 $97,960.00
Disclosure

SEC source: 0001567619-22-011443 · doc1.xml · nonDerivative · entry 1

Hair Mark · CIK 0001725070 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,150

Read SEC document
May 17, 2022 Filed May 20, 2022 00:39 UTC
Hanna BetsyDirector
GrantStock Option (Right to Buy) · Derivative 16,625 $0.00 Strike: $15.80 $0.00
Disclosure

SEC source: 0001567619-22-011345 · doc1.xml · derivative · entry 4

Hanna Betsy · CIK 0001885957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,625

Underlying: Common Stock · 16,625 shares

Expires 2032-05-17

F4 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 17, 2022 Filed May 20, 2022 00:39 UTC
Hanna BetsyDirector
GrantStock Option (Right to Buy) · Derivative 8,600 $0.00 Strike: $15.80 $0.00
Disclosure

SEC source: 0001567619-22-011345 · doc1.xml · derivative · entry 3

Hanna Betsy · CIK 0001885957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,600

Underlying: Common Stock · 8,600 shares

Expires 2032-05-17

F3 · derivative.exercise_date: The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on June 17, 2022 such that the stock option will be fully vested and exercisable on May 17, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 17, 2022 Filed May 20, 2022 00:39 UTC
Hanna BetsyDirector
GrantCommon Stock 2,295 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-011345 · doc1.xml · nonDerivative · entry 2

Hanna Betsy · CIK 0001885957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,482

F2 · shares: Represents RSUs for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date.

Read SEC document
May 17, 2022 Filed May 20, 2022 00:39 UTC
Hanna BetsyDirector
GrantCommon Stock 1,187 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-011345 · doc1.xml · nonDerivative · entry 1

Hanna Betsy · CIK 0001885957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,187

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will vest in three equal yearly installments starting May 17, 2023 such that the RSUs will be fully vested on May 17, 2025 subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 17, 2022 Filed May 20, 2022 00:33 UTC GrantStock Option (Right to Buy) · Derivative 16,625 $0.00 Strike: $15.80 $0.00
Disclosure

SEC source: 0001567619-22-011340 · doc1.xml · derivative · entry 4

BAKEWELL JOHN K · CIK 0001183553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,625

Underlying: Common Stock · 16,625 shares

Expires 2032-05-17

F2 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 17, 2022 Filed May 20, 2022 00:33 UTC GrantCommon Stock 2,295 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-011340 · doc1.xml · nonDerivative · entry 1

BAKEWELL JOHN K · CIK 0001183553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,295

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date.

Read SEC document
May 17, 2022 Filed May 19, 2022 20:38 UTC GrantStock Option (Right to Buy) · Derivative 16,625 $0.00 Strike: $15.80 $0.00
Disclosure

SEC source: 0001567619-22-011344 · doc1.xml · derivative · entry 4

TIMBIE THOMAS E · CIK 0001188309 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,625

Underlying: Common Stock · 16,625 shares

Expires 2032-05-17

F2 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 17, 2022 Filed May 19, 2022 20:38 UTC GrantCommon Stock 2,295 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-011344 · doc1.xml · nonDerivative · entry 1

TIMBIE THOMAS E · CIK 0001188309 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,295

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date.

Read SEC document
May 17, 2022 Filed May 19, 2022 20:37 UTC GrantStock Option (Right to Buy) · Derivative 16,625 $0.00 Strike: $15.80 $0.00
Disclosure

SEC source: 0001567619-22-011343 · doc1.xml · derivative · entry 2

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,625

Underlying: Common Stock · 16,625 shares

Expires 2032-05-17

F2 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through the vesting date.

Read SEC document
May 17, 2022 Filed May 19, 2022 20:37 UTC GrantCommon Stock 2,295 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-011343 · doc1.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,595,000

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date.

Read SEC document
May 17, 2022 Filed May 20, 2022 00:34 UTC GrantStock Option (Right to Buy) · Derivative 16,625 $0.00 Strike: $15.80 $0.00
Disclosure

SEC source: 0001567619-22-011341 · doc1.xml · derivative · entry 2

HAMILTON LAWRENCE W · CIK 0001326586 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,625

Underlying: Common Stock · 16,625 shares

Expires 2032-05-17

F2 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 17, 2022 Filed May 20, 2022 00:34 UTC GrantCommon Stock 2,295 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-011341 · doc1.xml · nonDerivative · entry 1

HAMILTON LAWRENCE W · CIK 0001326586 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,295

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date.

Read SEC document
May 17, 2022 Filed May 20, 2022 00:35 UTC
Jain DeeptiDirector
GrantStock Option (Right to Buy) · Derivative 16,625 $0.00 Strike: $15.80 $0.00
Disclosure

SEC source: 0001567619-22-011342 · doc1.xml · derivative · entry 4

Jain Deepti · CIK 0001840203 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,625

Underlying: Common Stock · 16,625 shares

Expires 2032-05-17

F4 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 17, 2022 Filed May 20, 2022 00:35 UTC
Jain DeeptiDirector
GrantStock Option (Right to Buy) · Derivative 8,600 $0.00 Strike: $15.80 $0.00
Disclosure

SEC source: 0001567619-22-011342 · doc1.xml · derivative · entry 3

Jain Deepti · CIK 0001840203 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,600

Underlying: Common Stock · 8,600 shares

Expires 2032-05-17

F3 · derivative.exercise_date: The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on June 17, 2022 such that the stock option will be fully vested and exercisable on May 17, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 17, 2022 Filed May 20, 2022 00:35 UTC
Jain DeeptiDirector
GrantCommon Stock 2,295 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-011342 · doc1.xml · nonDerivative · entry 2

Jain Deepti · CIK 0001840203 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,482

F2 · shares: Represents RSUs for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date.

Read SEC document
May 17, 2022 Filed May 20, 2022 00:35 UTC
Jain DeeptiDirector
GrantCommon Stock 1,187 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-011342 · doc1.xml · nonDerivative · entry 1

Jain Deepti · CIK 0001840203 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,187

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will vest in three equal yearly installments starting May 17, 2023 such that the RSUs will be fully vested on May 17, 2025 subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 09, 2022 Filed May 11, 2022 18:01 UTC
Owens Daniel E.Chief HR Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $7.03 $0.00
Disclosure

SEC source: 0001567619-22-010102 · doc1.xml · derivative · entry 3

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,625

Underlying: Common Stock · 1,000 shares

Expires 2031-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025.

Read SEC document
May 09, 2022 Filed May 11, 2022 18:01 UTC
Owens Daniel E.Chief HR Officer
SaleCommon Stock 1,000 $15.96 $15,960.00
Disclosure

SEC source: 0001567619-22-010102 · doc1.xml · nonDerivative · entry 2

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,700

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: Represents 6,700 RSUs.

Read SEC document
May 09, 2022 Filed May 11, 2022 18:01 UTC
Owens Daniel E.Chief HR Officer
Exercise / conversionCommon Stock 1,000 $7.03 $7,028.00
Disclosure

SEC source: 0001567619-22-010102 · doc1.xml · nonDerivative · entry 1

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Represents 6,700 RSUs.

Read SEC document
May 09, 2022 Filed May 11, 2022 17:59 UTC SaleCommon Stock 307 $15.97 $4,901.72
Disclosure

SEC source: 0001567619-22-010101 · doc1.xml · nonDerivative · entry 4

TREACE JOHN R · CIK 0001185249 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Treace and Ginger D. Treace JTTEN

Disclosed balance after: 1,822,790

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.96 to $15.97 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 09, 2022 Filed May 11, 2022 17:59 UTC SaleCommon Stock 18,415 $15.22 $280,197.12
Disclosure

SEC source: 0001567619-22-010101 · doc1.xml · nonDerivative · entry 3

TREACE JOHN R · CIK 0001185249 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Treace and Ginger D. Treace JTTEN

Disclosed balance after: 1,823,097

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.93 to $15.891 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 09, 2022 Filed May 11, 2022 17:59 UTC SaleCommon Stock 18,966 $14.20 $269,387.37
Disclosure

SEC source: 0001567619-22-010101 · doc1.xml · nonDerivative · entry 2

TREACE JOHN R · CIK 0001185249 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Treace and Ginger D. Treace JTTEN

Disclosed balance after: 1,841,512

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.93 to $14.86 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 09, 2022 Filed May 11, 2022 17:59 UTC SaleCommon Stock 37,312 $13.30 $496,189.90
Disclosure

SEC source: 0001567619-22-010101 · doc1.xml · nonDerivative · entry 1

TREACE JOHN R · CIK 0001185249 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Treace and Ginger D. Treace JTTEN

Disclosed balance after: 1,860,478

F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.93 to $13.86 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 09, 2022 Filed May 19, 2022 20:38 UTC GiftCommon Stock 120,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-011344 · doc1.xml · nonDerivative · entry 2

TIMBIE THOMAS E · CIK 0001188309 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Pamela Timbie and Thomas Timbie as Trustees of the PAMELA F TIMBIE REV TRUST

Disclosed balance after: 385,000

Read SEC document
March 10, 2022 Filed Mar 10, 2022 20:25 UTC GiftCommon Stock 105,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-006731 · doc1.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,592,705

Read SEC document
March 10, 2022 Filed Mar 14, 2022 18:01 UTC SaleCommon Stock 2 $19.21 $38.41
Disclosure

SEC source: 0001567619-22-006925 · doc1.xml · nonDerivative · entry 2

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By J&A Group LLC

Disclosed balance after: 0

F1 · ownership.nature: James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 20:27 UTC
Owens Daniel E.Chief HR Officer
GrantStock Option (Right to Buy) · Derivative 51,600 $0.00 Strike: $19.15 $0.00
Disclosure

SEC source: 0001567619-22-006734 · doc1.xml · derivative · entry 2

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,600

Underlying: Common Stock · 51,600 shares

Expires 2032-03-08

F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 20:27 UTC
Owens Daniel E.Chief HR Officer
GrantCommon Stock 6,700 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-006734 · doc1.xml · nonDerivative · entry 1

Owens Daniel E. · CIK 0001858105 · Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,700

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Represents 6,700 RSUs.

Read SEC document
March 08, 2022 Filed Mar 11, 2022 01:26 UTC
Scanlan Sean F.SVP, Marketing
GrantStock Option (Right to Buy) · Derivative 50,650 $0.00 Strike: $19.15 $0.00
Disclosure

SEC source: 0001567619-22-006733 · doc1.xml · derivative · entry 2

Scanlan Sean F. · CIK 0001856371 · SVP, Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,650

Underlying: Common Stock · 50,650 shares

Expires 2032-03-08

F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
March 08, 2022 Filed Mar 11, 2022 01:26 UTC
Scanlan Sean F.SVP, Marketing
GrantCommon Stock 6,575 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-006733 · doc1.xml · nonDerivative · entry 1

Scanlan Sean F. · CIK 0001856371 · SVP, Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,575

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Includes 6,575 RSUs.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 20:21 UTC
Frias Jaime A.Chief Legal Officer
GrantStock Option (Right to Buy) · Derivative 60,800 $0.00 Strike: $19.15 $0.00
Disclosure

SEC source: 0001567619-22-006727 · doc1.xml · derivative · entry 3

Frias Jaime A. · CIK 0001856367 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,800

Underlying: Common Stock · 60,800 shares

Expires 2022-03-08

F5 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 20:21 UTC
Frias Jaime A.Chief Legal Officer
GrantCommon Stock 7,875 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-006727 · doc1.xml · nonDerivative · entry 1

Frias Jaime A. · CIK 0001856367 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,659

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Includes 7,875 RSUs.

F3 · balance_after: On April 29, 2021, a Form 4 was filed, which inadvertently reported that, following a stock split related to the Issuer's IPO, the Reporting Person directly owned 42,786 shares of Common Stock. Applying the correct stock split ratio, which rounded down fractional shares, the Reporting Person indirectly owned 42,784 shares. This correction has been reflected in this filing.

Read SEC document
March 08, 2022 Filed Mar 11, 2022 01:24 UTC
Treace John T.Director · Chief Executive Officer · 10% owner
GrantStock Option (Right to Buy) · Derivative 20,884 $0.00 Strike: $21.07 $0.00
Disclosure

SEC source: 0001567619-22-006730 · doc1.xml · derivative · entry 7

Treace John T. · CIK 0001856380 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,884

Underlying: Common Stock · 20,884 shares

Expires 2027-03-08

F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.